Our Objectives

Our Objectives

LuCE aims to raise awareness about inequities regarding the access to lung cancer treatment and care in Europe. Moreover, it advocates European policies that will lead to improvements in lung cancer prevention, early detection, treatment and care.

Read More

Our Members

Our Members

Lung Cancer Europe provides a European platform for national lung cancer patient advocacy groups and supports the establishment of those groups in countries where such groups do not yet exist. Our member organisations and associate members come from all over Europe.

Read More

Our Diagnosis

Our Diagnosis

Lung cancer is literally the biggest cancer killer worldwide – causing more deaths than breast and prostate cancer put together all over the world. Read more about our diagnosis, types and stages of lung cancer, treatments and clinical trials, but also how to cope with lung cancer.

Read More

Investing in the future: Improving cancer biomarker testing and cancer diagnosis for sustainable healthcare

Investing in the future: Improving cancer biomarker testing and cancer diagnosis for sustainable healthcare is a new white paper co-authored by a team of medical and patient advocacy experts, including representatives from the ECPC, Oncohealth Institute and Fight Bladder Cancer. The white paper calls for increased access to cancer biomarker testing, to identify those who will benefit most from precision […]

Read More

Living with lung cancer: Survivorship and quality of life – Survey for patients and caregivers

Since its establishment, LuCE has continually developed a range of reports tackling relevant challenges for the lung cancer community, such as access to treatment, care and testing, as well as issues around clinical trials in Europe. LuCE plans to develop a report on “Living with lung cancer: survivorship and quality of life” to explore how patients´ and caregivers´ lives have […]

Read More

LuCE Webinar: Current research lines in lung cancer

Lung Cancer Europe (LuCE) held a webinar on current research lines in lung cancer. The webinar was given by Professor Simon Ekman, Senior Consultant and Associate Professor in Oncology at Karolinska University Hospital in Stockholm in Sweden. The webinar was held and recorded on 29th April 2021.

Read More